Pouch, Ileal clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
Sorry, in progress, not accepting new patients
The goal of this clinical trial is to learn if mirikizumab works to treat pouch disorders in adults. The main questions it aims to answer are: Does mirikizumab reduce symptoms of pouch disorders Participants will: Take mirikizumab every 4 weeks for one year Visit the clinic once every month for two months and at the end of the study Keep a diary of their symptoms
at UCLA
Last updated: